Wollenhaupt J, Silverfield J, Lee B, et al. Tofacitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in open-label, long-term extension studies over 8 years. EULAR 2017, THU0197.
Langetermijnresultaten tocilizumab bij RA-patiënten met onvoldoende respons op csDMARD of anti-TNF
okt 2019 | RA